Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J H Powell

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Journal of Clinical Pharmacology|December 10, 1999
Azimilide pharmacokinetics following intravenous and oral administration of a solution and capsule formulationA E Corey, J R Agnew, S N Valentine, et al.
Biopharmaceutics & Drug Disposition|April 17, 2001
Absence of pharmacokinetic interaction between orally co-administered naproxen sodium and diphenhydramine hydrochlorideR D Toothaker, S H Barker, M V Gillen, et al.
British Journal of Clinical Pharmacology|March 16, 2000
Comparative oral bioavailability of azimilide dihydrochloride in the fed and fasted statesA E Corey, J R Agnew, S N Valentine, et al.
Climacteric : the Journal of the International Menopause Society|March 26, 2002
Significant differences in estradiol bioavailability from two similarly labelled estradiol matrix transdermal systemsA B Buch, L Z Shen, S C Kelly, et al.
Psychology & Health|July 25, 2022
Pragmatic evaluation of methods for retrieving unpublished information on comparator interventions in a systematic review of smoking cessation trialsNeža Javornik, Daniel J H Powell, Maarten C Eisma, et al.
Pharmaceutical Research|June 19, 2001
Risedronate pharmacokinetics and intra- and inter-subject variability upon single-dose intravenous and oral administrationD Y Mitchell, W H Barr, R A Eusebio, et al.
Archives of Toxicology. Supplement. = Archiv Fur Toxikologie. Supplement|January 1, 1995
Safety assessment of OTC drugs: doxylamine succinateJ A Skare, V A Murphy, R C Bookstaff, et al.
Journal of Clinical Pharmacology|March 10, 2000
Dose-proportional pharmacokinetics of risedronate on single-dose oral administration to healthy volunteersD Y Mitchell, R A Eusebio, N A Sacco-Gibson, et al.
British Journal of Clinical Pharmacology|March 16, 2000
Effect of renal function on risedronate pharmacokinetics after a single oral doseD Y Mitchell, J V St Peter, R A Eusebio, et al.
Journal of Pharmaceutical Sciences|November 1, 1996
Assessment of doxylamine influence on mixed function oxidase activity upon multiple dose oral administration to normal volunteersG A Thompson, J V St Peter, M A Heise, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Journal of Clinical Pharmacology|December 10, 1999
Azimilide pharmacokinetics following intravenous and oral administration of a solution and capsule formulationA E Corey, J R Agnew, S N Valentine, et al.
Biopharmaceutics & Drug Disposition|April 17, 2001
Absence of pharmacokinetic interaction between orally co-administered naproxen sodium and diphenhydramine hydrochlorideR D Toothaker, S H Barker, M V Gillen, et al.
British Journal of Clinical Pharmacology|March 16, 2000
Comparative oral bioavailability of azimilide dihydrochloride in the fed and fasted statesA E Corey, J R Agnew, S N Valentine, et al.
Climacteric : the Journal of the International Menopause Society|March 26, 2002
Significant differences in estradiol bioavailability from two similarly labelled estradiol matrix transdermal systemsA B Buch, L Z Shen, S C Kelly, et al.
Psychology & Health|July 25, 2022
Pragmatic evaluation of methods for retrieving unpublished information on comparator interventions in a systematic review of smoking cessation trialsNeža Javornik, Daniel J H Powell, Maarten C Eisma, et al.
Pharmaceutical Research|June 19, 2001
Risedronate pharmacokinetics and intra- and inter-subject variability upon single-dose intravenous and oral administrationD Y Mitchell, W H Barr, R A Eusebio, et al.
Archives of Toxicology. Supplement. = Archiv Fur Toxikologie. Supplement|January 1, 1995
Safety assessment of OTC drugs: doxylamine succinateJ A Skare, V A Murphy, R C Bookstaff, et al.
Journal of Clinical Pharmacology|March 10, 2000
Dose-proportional pharmacokinetics of risedronate on single-dose oral administration to healthy volunteersD Y Mitchell, R A Eusebio, N A Sacco-Gibson, et al.
British Journal of Clinical Pharmacology|March 16, 2000
Effect of renal function on risedronate pharmacokinetics after a single oral doseD Y Mitchell, J V St Peter, R A Eusebio, et al.
Journal of Pharmaceutical Sciences|November 1, 1996
Assessment of doxylamine influence on mixed function oxidase activity upon multiple dose oral administration to normal volunteersG A Thompson, J V St Peter, M A Heise, et al.
Pageof 4